The global anatomic pathology market is projected to grow from USD 8.9 billion in 2026 to USD 14.5 billion by 2031, at a CAGR of 10.2% during the forecast period. The market was valued at USD 8.2 billion in 2025. Market growth is primarily driven by the increasing global burden of cancer and the growing demand for accurate tissue- and cell-based diagnosis across a wide range of diseases.
Rising adoption of biomarker assessment, enhanced focus on disease characterization, and expanding utilization of histopathology and cytopathology services are supporting market expansion. Additionally, advancements in laboratory automation, digital pathology, artificial intelligence-enabled image analysis, and integrated pathology workflows are improving diagnostic efficiency and consistency. Increasing healthcare expenditure, expanding access to specialized pathology services, and ongoing investments in precision diagnostics and pathology infrastructure are further contributing to the sustained growth of the anatomic pathology market.
Spotlights on the Industry’s Leading Anatomic Pathology Companies
The anatomic pathology market is evolving rapidly, driven by advances in diagnostic technologies, laboratory automation, digital pathology, biomarker analysis, and precision medicine. In this dynamic environment, the following companies stand out for their technological capabilities, diagnostic portfolios, strategic investments, and contributions to pathology workflows worldwide.
1. F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is a major player in anatomic pathology, supported by its broad portfolio of diagnostic technologies, tissue-based assays, and companion diagnostic solutions. The company focuses on improving disease characterization and supporting precision medicine through advanced pathology and biomarker assessment technologies. Its integrated approach to diagnostics strengthens pathology workflows across clinical and research environments.
2. Danaher Corporation
Danaher Corporation maintains a strong position in the anatomic pathology market through its diverse portfolio of diagnostic, laboratory, and pathology-related technologies. Its businesses support tissue processing, staining, imaging, and digital pathology workflows. Continued investments in automation, workflow integration, and advanced diagnostic technologies enable laboratories to improve efficiency and standardization.
3. PHC Holdings Corporation
PHC Holdings Corporation contributes to the anatomic pathology market through laboratory and diagnostic solutions designed to support efficient pathology workflows. The company’s focus on automation, laboratory infrastructure, and diagnostic technologies addresses the growing need for reliable and standardized pathology processes. Its solutions support healthcare providers seeking improved operational efficiency and diagnostic consistency.
4. Hologic, Inc.
Hologic, Inc. is recognized for its strong presence in women’s health and diagnostic technologies, with capabilities spanning cytology and molecular diagnostic applications. Its pathology-related solutions support the detection and characterization of diseases, particularly in cervical health and cancer screening. The company’s focus on automation and diagnostic accuracy strengthens its role in evolving pathology workflows.
5. Agilent Technologies, Inc.
Agilent Technologies, Inc. offers technologies that support tissue-based diagnostics, immunohistochemistry, and biomarker analysis. Its pathology solutions enable laboratories to perform advanced staining and molecular characterization for disease diagnosis. Continued innovation in reagents, instrumentation, and workflow solutions supports the growing demand for precision pathology.
6. Becton, Dickinson and Company
Becton, Dickinson and Company (BD) provides diagnostic and laboratory technologies that contribute to anatomic pathology and cytology workflows. Its capabilities in specimen preparation, cellular analysis, and laboratory automation support efficient diagnostic processes. The company’s global presence and focus on workflow standardization position it to benefit from increasing demand for advanced pathology services.
7. Koninklijke Philips N.V.
Koninklijke Philips N.V. plays an important role in the transition toward digital pathology through imaging, visualization, and digital workflow technologies. Its solutions help laboratories digitize pathology processes and support collaboration among pathologists. The integration of digital imaging and advanced analytics is expected to remain an important area of development as pathology laboratories modernize.
8. Merck KGaA
Merck KGaA contributes to anatomic pathology through technologies and products supporting life science research, diagnostics, and biomarker analysis. Its portfolio helps researchers and laboratories investigate cellular and tissue characteristics relevant to disease diagnosis and treatment. The company’s expertise across life sciences supports the broader shift toward molecularly informed pathology.
9. Bio SB
Bio SB specializes in pathology reagents and immunohistochemistry products used for tissue-based diagnostic applications. Its portfolio supports laboratories in biomarker detection and disease characterization. By providing antibodies, detection systems, and related pathology products, the company addresses the growing demand for reliable immunohistochemical testing.
10. Sakura Finetek Japan Co., Ltd.
Sakura Finetek Japan Co., Ltd. is a prominent provider of solutions for histopathology and tissue processing. Its technologies support key laboratory steps including tissue preparation, processing, embedding, staining, and workflow automation. The company’s focus on improving laboratory efficiency and standardization aligns with the increasing adoption of automated pathology workflows.
11. BIOGENEX
BIOGENEX provides solutions focused on immunohistochemistry and tissue-based diagnostics. Its technologies support automated staining and biomarker detection, helping pathology laboratories improve workflow efficiency and reproducibility. The company’s emphasis on automation addresses the growing need for standardized and scalable pathology testing.
12. MILESTONE MEDICAL
MILESTONE MEDICAL develops laboratory technologies supporting tissue processing and pathology workflows. Its solutions are designed to improve the efficiency and consistency of specimen preparation, an important component of modern histopathology laboratories. The company’s focus on automation contributes to the modernization of conventional pathology processes.
13. HISTO-LINE LABORATORIES
HISTO-LINE LABORATORIES provides equipment and solutions for histology and anatomic pathology applications. Its portfolio supports tissue processing, preparation, and laboratory workflows used in diagnostic pathology. The company’s focus on practical laboratory technologies contributes to the expanding adoption of efficient pathology processes.
14. DIAPATH S.P.A.
DIAPATH S.P.A. specializes in equipment, reagents, and consumables for histology and cytology laboratories. Its solutions support multiple stages of the pathology workflow, from specimen preparation to staining and examination. The company’s emphasis on laboratory efficiency and pathology workflow solutions strengthens its presence in the global anatomic pathology market.
Conclusion: Access the Full Anatomic Pathology Market Intelligence
The anatomic pathology market is entering a period of sustained transformation, driven by the increasing incidence of cancer, growing demand for accurate tissue-based diagnosis, and rapid adoption of automation and digital pathology. Biomarker assessment, immunohistochemistry, histopathology, cytopathology, artificial intelligence, and integrated pathology workflows are expected to remain key areas shaping the competitive landscape.
The companies highlighted above represent important participants in the development of technologies and solutions supporting modern anatomic pathology. Their continued investments in automation, digitalization, diagnostic accuracy, and precision medicine are expected to influence the evolution of pathology laboratories worldwide.
